Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

IL-6-PAD4 axis in the earliest phase of arthritis in knock-in gp130F759 mice, a model for rheumatoid arthritis.

Yahagi A, Saika T, Hirano H, Takai-Imamura M, Tsuji F, Aono H, Iseki M, Morita Y, Igarashi H, Saeki Y, Ishihara K.

RMD Open. 2019 Jun 21;5(2):e000853. doi: 10.1136/rmdopen-2018-000853. eCollection 2019.

2.

GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.

Sawada Y, Kikugawa T, Iio H, Sakakibara I, Yoshida S, Ikedo A, Yanagihara Y, Saeki N, Győrffy B, Kishida T, Okubo Y, Nakamura Y, Miyagi Y, Saika T, Imai Y.

Int J Cancer. 2019 Jul 5. doi: 10.1002/ijc.32554. [Epub ahead of print]

PMID:
31276604
3.

[Development of Novel Immobilization Adapter for Head and Neck Radiotherapy with Low-attenuation Material].

Matsumoto K, Saika T, Shimomura K, Hanaoka K, Tamura M, Monzen H, Hayakawa M, Okumura M.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(2):167-173. doi: 10.6009/jjrt.2019_JSRT_75.2.167. Japanese.

4.

Case Report of Living Kidney Transplantation Using Ectopic Pelvic Kidney Harvested by Reduced Port Laparoscopic Donor Nephrectomy.

Miyauchi Y, Noda T, Miura N, Kikugawa T, Saika T.

Transplant Proc. 2018 Dec;50(10):3917-3919. doi: 10.1016/j.transproceed.2018.06.016. Epub 2018 Jun 22.

PMID:
30586841
5.

New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma.

Asai S, Fukumoto T, Watanabe R, Koyama K, Sawada Y, Noda T, Miura N, Yanagihara Y, Miyauchi Y, Miyagawa M, Kikugawa T, Saika T.

Jpn J Clin Oncol. 2018 Nov 1;48(11):1022-1027. doi: 10.1093/jjco/hyy135.

PMID:
30252103
6.

Dewaxed Brown Rice Feed Improves Fatty Liver in Obese and Diabetic Model Mice.

Inagawa H, Saika T, Nishiyama N, Nisizawa T, Kohchi C, Uenobe M, Soma GI.

Anticancer Res. 2018 Jul;38(7):4339-4345. doi: 10.21873/anticanres.12734.

PMID:
29970571
7.

Renal Function after Nephrectomy Influences the Risk of Cardiovascular Events.

Kambara T, Tanimoto R, Araki M, Saika T, Hashimoto H, Oeda T, Tsushima T, Hayata S, Nasu Y, Kobayashi Y.

Acta Med Okayama. 2018 Jun;72(3):241-247. doi: 10.18926/AMO/56069.

8.

The Combination of Gemcitabine, Cisplatin, and Paclitaxel as Salvage Chemotherapy for Advanced Urothelial Carcinoma.

Hirata T, Hanamoto M, Ogura K, Hayashi N, Takamura K, Edamura K, Ebara S, Saika T.

Acta Med Okayama. 2018 Apr;72(2):175-179. doi: 10.18926/AMO/55858.

9.

Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.

Asai S, Miura N, Sawada Y, Noda T, Kikugawa T, Tanji N, Saika T.

Oncol Lett. 2018 Jan;15(1):522-527. doi: 10.3892/ol.2017.7269. Epub 2017 Oct 26.

10.

Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.

Tanimoto R, Saika T, Ebara S, Kobayashi Y, Nasu R, Yamada D, Takamoto H, Miyaji Y, Nasu Y, Tsushima T, Kumon H.

World J Urol. 2018 Jun;36(6):889-895. doi: 10.1007/s00345-018-2196-8. Epub 2018 Jan 31.

PMID:
29387931
11.

Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.

Saika T, Miura N, Fukumoto T, Yanagihara Y, Miyauchi Y, Kikugawa T.

Int J Urol. 2018 Jan;25(1):30-35. doi: 10.1111/iju.13441. Epub 2017 Sep 13. Review.

12.

Improvement Effect of Dewaxed Brown Rice on Constipation in Antibiotic-treated Mice.

Inagawa H, Saika T, Nishiyama N, Nisizawa T, Kohchi C, Uenobe M, Soma GI.

In Vivo. 2017 Jul-Aug;31(4):573-577.

13.

Dewaxed Brown Rice Contains a Significant Amount of Lipopolysaccharide Pointing to Macrophage Activation via TLRs.

Inagawa H, Saika T, Nisizawa T, Kohchi C, Uenobe M, Soma G.

Anticancer Res. 2016 Jul;36(7):3599-605.

PMID:
27354629
14.

[Quantitative Evaluation of Metal Artifacts on CT Images on the Basis of Statistics of Extremes].

Kitaguchi S, Imai K, Ueda S, Hashimoto N, Hattori S, Saika T, Ono Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2016 May;72(5):402-9. doi: 10.6009/jjrt.2016_JSRT_72.5.402. Japanese.

15.

[OCULAR SYMPTOMS OF CEDAR POLLINOSIS IN OTOLARYNGOLOGY].

Hyo Y, Fujisaki T, Hamamoto M, Saika T, Harada T.

Arerugi. 2015 Aug;64(8):1153-9. doi: 10.15036/arerugi.64.1153. Japanese.

PMID:
26522417
16.

Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients.

Mizote Y, Uenaka A, Isobe M, Wada H, Kakimi K, Saika T, Kita S, Koide Y, Oka M, Nakayama E.

Vaccine. 2014 Feb 12;32(8):957-64. doi: 10.1016/j.vaccine.2013.12.042. Epub 2014 Jan 5.

PMID:
24397899
17.

Anti-apoptotic roles for the mutant p53R248Q through suppression of p53-regulated apoptosis-inducing protein 1 in the RA-derived fibroblast-like synoviocyte cell line MH7A.

Igarashi H, Hirano H, Yahagi A, Saika T, Ishihara K.

Clin Immunol. 2014 Jan;150(1):12-21. doi: 10.1016/j.clim.2013.10.013. Epub 2013 Nov 5.

PMID:
24316591
18.

Laparoscopic-assisted tension-free vaginal mesh: an innovative approach to placing synthetic mesh: transvaginally for surgical correction of pelvic organ prolapse.

Watanabe T, Inoue M, Ishii A, Yamato T, Yamamoto M, Sasaki K, Kobayashi Y, Araki M, Uehara S, Saika T, Kumon H.

Acta Med Okayama. 2012;66(1):23-9.

19.

Laparoscopic management of complicated urachal remnants in adults.

Araki M, Saika T, Araki D, Kobayashi Y, Uehara S, Watanabe T, Yamada K, Nasu Y, Kumon H.

World J Urol. 2012 Oct;30(5):647-50.

PMID:
22290478
20.

[Antimicrobial susceptibility profile of Acinetobacter baumannii complex isolates in Japan].

Ikeda F, Amano A, Iyoda T, Matsuzaki K, Hasegawa M, Saika T, Kanayama A, Kobayashi I.

Kansenshogaku Zasshi. 2011 Sep;85(5):501-7. Japanese.

PMID:
22117378
21.

Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?

Bekku K, Saika T, Kobayashi Y, Kioshimoto R, Kanbara T, Nasu Y, Kumon H.

Int J Clin Oncol. 2013 Feb;18(1):110-5. doi: 10.1007/s10147-011-0350-z. Epub 2011 Nov 18.

22.

A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis.

Igarashi H, Yahagi A, Saika T, Hashimoto J, Tomita T, Yoshikawa H, Ishihara K.

Immunol Lett. 2012 Jan 30;141(2):246-53. doi: 10.1016/j.imlet.2011.10.011. Epub 2011 Nov 9.

PMID:
22093807
23.

[Nationwide antimicrobial susceptibility survey of Neisseria gonorrhoeae isolates in Japan].

Tanaka M, Shimojima M, Saika T, Iyoda T, Ikeda F, Kanayama A, Kobayashi I.

Kansenshogaku Zasshi. 2011 Jul;85(4):360-5. Japanese.

PMID:
21861439
24.

The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy.

Kishimoto R, Saika T, Bekku K, Nose H, Abarzua F, Kobayashi Y, Araki M, Yanai H, Nasu Y, Kumon H.

World J Urol. 2012 Jun;30(3):375-8. doi: 10.1007/s00345-011-0738-4. Epub 2011 Aug 17.

PMID:
21847658
25.

Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrug-resistant phenotypes.

Tanaka M, Koga Y, Nakayama H, Kanayama A, Kobayashi I, Saika T, Iyoda T.

Sex Transm Dis. 2011 Sep;38(9):871-5. doi: 10.1097/OLQ.0b013e31821d0f98.

PMID:
21844744
26.

Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Kobayashi Y, Saika T, Miyaji Y, Saegusa M, Arata R, Akebi N, Takenaka T, Manabe D, Nasu Y, Kumon H.

World J Urol. 2012 Apr;30(2):271-5. doi: 10.1007/s00345-011-0731-y. Epub 2011 Jul 30.

PMID:
21805177
27.

Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer.

Uesugi T, Saika T, Edamura K, Nose H, Kobuke M, Ebara S, Abarzua F, Katayama N, Yanai H, Nasu Y, Kumon H.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e219-23. doi: 10.1016/j.ijrobp.2011.04.018. Epub 2011 Jun 2.

PMID:
21640517
28.

Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.

Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M.

Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45. doi: 10.1128/AAC.00325-11. Epub 2011 May 16.

29.

Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.

Huang P, Chen J, Wang L, Na Y, Kaku H, Ueki H, Sasaki K, Yamaguchi K, Zhang K, Saika T, Nasu Y, Watanabe M, Kumon H.

Med Oncol. 2012 Jun;29(2):829-34. doi: 10.1007/s12032-011-9962-4. Epub 2011 May 1.

PMID:
21533858
30.

Prognostic factors influencing survival after nephroureterectomy for transitional cell carcinoma of the upper urinary tract.

Kobayashi Y, Saika T, Manabe D, Nasu Y, Kumon H.

Acta Med Okayama. 2011 Apr;65(2):143-9.

31.

[In vitro activity of sitafloxacin against clinical isolates in 2009].

Amano A, Matsuzaki K, Kishi N, Saika T, Hasegawa M, Ikeda F, Matsumoto T, Yamaguchi H, Kanda Y, Shiozawa T.

Jpn J Antibiot. 2010 Dec;63(6):411-30. Japanese.

PMID:
21425595
32.

Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.

Kawada J, Wada H, Isobe M, Gnjatic S, Nishikawa H, Jungbluth AA, Okazaki N, Uenaka A, Nakamura Y, Fujiwara S, Mizuno N, Saika T, Ritter E, Yamasaki M, Miyata H, Ritter G, Murphy R, Venhaus R, Pan L, Old LJ, Doki Y, Nakayama E.

Int J Cancer. 2012 Feb 1;130(3):584-92. doi: 10.1002/ijc.26074. Epub 2011 May 25.

33.

Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.

Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, Kitawaki J.

Emerg Infect Dis. 2011 Jan;17(1):148-9. doi: 10.3201/eid1701.100397. No abstract available.

34.

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.

Watanabe T, Inoue M, Sasaki K, Araki M, Uehara S, Monden K, Saika T, Nasu Y, Kumon H, Chancellor MB.

BJU Int. 2011 Jul;108(2):248-51. doi: 10.1111/j.1464-410X.2010.09716.x. Epub 2010 Sep 30.

35.

Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.

Mizote Y, Taniguchi T, Tanaka K, Isobe M, Wada H, Saika T, Kita S, Koide Y, Uenaka A, Nakayama E.

Vaccine. 2010 Jul 19;28(32):5338-46.

36.

Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.

Kanayama A, Iyoda T, Matsuzaki K, Saika T, Ikeda F, Ishii Y, Yamaguchi K, Kobayashi I.

Int J Antimicrob Agents. 2010 Oct;36(4):340-2. doi: 10.1016/j.ijantimicag.2010.06.002. Epub 2010 Jul 7.

PMID:
20609568
37.

Indications for ureteropyeloscopy based on radiographic findings and urine cytology in detection of upper urinary tract carcinoma.

Takao A, Saika T, Uehara S, Monden K, Abarzua F, Nasu Y, Kumon H; Okayama Urological Research Group.

Jpn J Clin Oncol. 2010 Nov;40(11):1087-91. doi: 10.1093/jjco/hyq096. Epub 2010 Jun 24.

PMID:
20581003
38.

Prognostic factors influencing survival after nephroureterectomy for transitional cell carcinoma of the upper urinary tract.

Kobayashi Y, Saika T, Manabe D, Nasu Y, Kumon H.

Acta Med Okayama. 2010 Feb;64(1):27-31. Erratum in: Acta Med Okayama. 2011 Apr;65(2):143-4. Corrected and republished in: Acta Med Okayama. 2011 Apr;65(2):143-9.

39.

Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma.

Huang P, Kaku H, Chen J, Kashiwakura Y, Saika T, Nasu Y, Urata Y, Fujiwara T, Watanabe M, Kumon H.

Cancer Gene Ther. 2010 Jul;17(7):484-91. doi: 10.1038/cgt.2010.5. Epub 2010 Feb 19.

40.

A comparison of proteomic profiles changes during 17beta-estradiol treatment in human prostate cancer PC-3 cell line.

Chen J, Huang P, Kaku H, Zhang K, Watanabe M, Saika T, Nasu Y, Kumon H.

Cancer Genomics Proteomics. 2009 Nov-Dec;6(6):331-5.

41.

Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study.

Saika T, Tsushima T, Nasu Y, Miyaji Y, Saegusa M, Takeda K, Kumon H.

World J Urol. 2010 Aug;28(4):413-8. doi: 10.1007/s00345-009-0502-1. Epub 2010 Jan 8.

PMID:
20054553
43.

Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.

Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, Hatta M, Yamamoto N, Kunishima H, Yano H, Kitagawa M, Arai K, Kawakami K, Kobayashi I, Jones RN, Kohno S, Yamaguchi K, Kaku M.

Antimicrob Agents Chemother. 2009 Oct;53(10):4225-30. doi: 10.1128/AAC.00192-09. Epub 2009 Aug 3.

44.

Prospective longitudinal comparative study of health-related quality of life in patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.

Kobuke M, Saika T, Nakanishi Y, Ebara S, Manabe D, Uesugi T, Nose H, Arata R, Tsushima T, Nasu Y, Kumon H.

Acta Med Okayama. 2009 Jun;63(3):129-35.

45.

Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations.

Murakami K, Okimoto T, Kodama M, Tanahashi J, Fujioka T, Ikeda F, Muraoka H, Takigawa M, Saika T, Hasegawa M, Kobayashi I.

Antimicrob Agents Chemother. 2009 Jul;53(7):3097-9. doi: 10.1128/AAC.01552-08. Epub 2009 Apr 20.

46.

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.

Domae S, Nakamura Y, Nakamura Y, Uenaka A, Wada H, Nakata M, Oka M, Kishimoto K, Tsukamoto G, Yoshihama Y, Matsuoka J, Gochi A, Kohno S, Saika T, Sasaki A, Nakayama E, Ono T.

Int J Cancer. 2009 May 15;124(10):2347-52. doi: 10.1002/ijc.24220.

47.

Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.

Naito S, Yamamoto N, Takayama T, Muramoto M, Shinohara N, Nishiyama K, Takahashi A, Maruyama R, Saika T, Hoshi S, Nagao K, Yamamoto S, Sugimura I, Uemura H, Koga S, Takahashi M, Ito F, Ozono S, Terachi T, Naito S, Tomita Y.

Eur Urol. 2010 Feb;57(2):317-25. doi: 10.1016/j.eururo.2008.12.026. Epub 2009 Jan 3.

PMID:
19136199
48.

Mechanistic analysis of resistance to REIC/Dkk-3-induced apoptosis in human bladder cancer cells.

Kobayashi T, Sakaguchi M, Tanimoto R, Abarzua F, Takaishi M, Kaku H, Kataoka K, Saika T, Nasu Y, Miyazaki M, Kumon H, Huh NH.

Acta Med Okayama. 2008 Dec;62(6):393-401.

49.

Initial report of hybrid radical prostatectomy for prostate cancer: reduced bleeding, clear vision, and secure surgical margins.

Saika T, Kobayashi Y, Watanabe T, Manabe D, Ebara S, Uehara S, Nasu Y, Kumon H.

Acta Med Okayama. 2008 Dec;62(6):379-84.

50.

Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity.

Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, Saika T, Miyamura T, Chayama K, Nakamura Y, Wada H, Yamashita T, Morishima T, Old LJ, Nakayama E.

Cancer Immun. 2008 Nov 13;8:15.

Supplemental Content

Support Center